P2-135: Establishments of Gemcitabine-Resistant Cell Lines A549/Gem and NCI-H460 and Studies about Their Biological Characters
Weixia Wang,Xiaoqing Liu,Guangxian Liu,Xiaoling Zheng,Yunfeng Zhu,Xiaobing Li
DOI: https://doi.org/10.1097/01.jto.0000283599.63232.69
IF: 20.121
2007-01-01
Journal of Thoracic Oncology
Abstract:To establish human gemcitabine-resistant non-small cell lung cancer cell lines and discuss their biological characters so as to elaborate the possible mechanisms of gemcitabine resistance. Two human Gemcitabine-Resistant non-small cell lung cancer cell lines A549/Gem and H460/Gem were established by repeated clinical serous peak concentration then low but gradually increasing concentration of gemcitabine and 2/3 clinical serous peak concentration gemcitabine intermittent selection from their parental cells human lung adenocarcinoma cell line A549 and human large cell lung cancinoma cell line NCI-H460 who are sensitive to gemcitabine respectively. During the course of inducement, we had monitored their morphology, checked their resistance indexes and resistant pedigree by MTT method, gathered their growth curves and calculated their doubling time, examined their DNA contents and cell cycles by FCM; at the same time, we had measured their expression of P53, EGFR, c-erb-B-2, PTEN, PCNA, c-myc, VEGF, MDR-1, Bcl-2, nm23, MMP-9, TIMP-1 and CD44v6 Proteins. The resistance indexes of A549/Gem and H460/Gem to gemcitabine are 1.644 and 129.783, respectively, and the cell lines also exhibits respectively cross-resistance to vinorelbine, docetaxel, etoposide, cisplatin and taxol, etoposide, cisplatin. Compared with their parental cells, A549/Gem and H460/Gem are mixed with giant cells of different sizes that are larger and more irregular. The doubling time of A549/Gem is shorter and figures in G0-G1 phase are increased. Meanwhile, H460/Gem have developed contrary changes. Furthermore, they produced different results in different checkpoints. The farther studies indicated that compared with A549, PTEN expression of A549/Gem had been (−) and then rises, MMP-9 expression rises, EGFR TIMP-1 and c-myc (+), P53 c-erb-B-2 and bcl-2 drops, nm23 rises and then (−), and PCNA, MDR-1 (−). Compared with NCI-H460, H460/Gem had exhibited TIMP-9 (+) and P53 CD44v6 (−), then c-erb-B-2 (+), increased expression of nm23 bcl-2 MDR-1 and decreased expression of MMP-9 VEGF P53. The human gemcitabine-resistant non-small cell lung cancer cell lines A549/Gem and H46/Gem have achieved multi-drug resistance and great changes of biological characters compared with their parental cells. And these changes possibly participate in the formation of multidrug resistance.